Scientific articles and guides about Mounjaro, Zepbound and tirzepatide
Many patients on tirzepatide notice their favorite foods tasting different. Learn what's behind these taste changes and what the science says about this unexpected effect.
The pharmaceutical battle between Novo Nordisk and Eli Lilly is reshaping pricing, access, and workplace benefits for weight loss medications. Here is what patients and employers need to know.
Wondering why injectable GLP-1 medications often seem to work better for sweet and salty food cravings than oral versions? The answer lies in how each formulation reaches your body's GLP-1 receptors.
Clinical weight loss with tirzepatide targets appetite and metabolism through a dual GIP/GLP-1 mechanism. Learn how it works, who qualifies, and what outcomes to expect.
Headaches rank among the most frequently reported adverse events during tirzepatide treatment. Here is what the clinical data and mechanism of action tell us about why they occur and what influences their course.
GLP-1 medications are moving from the clinic to the corporate benefits package. Here's what's driving this shift and what it means for employers and workers alike.
Tirzepatida exige acompanhamento médico regular. Entenda o que acontece nas consultas, quais exames fazer e como construir uma relação sólida com seu endocrinologista durante o tratamento.
Curious about the monthly cost of tirzepatide? This guide breaks down list prices, insurance coverage, pharmacy options, and the true investment required for long-term treatment.
Brazil's medical council warned physicians about compounded tirzepatide. Here's what the alert means for patients and doctors navigating treatment options.
Gastrointestinal side effects are common with tirzepatide and often limit treatment success. Here is what researchers are investigating to improve tolerability.
Answer a few quick questions and get tailored guidance for your treatment.
or download the app
